MiR-155 plays an oncogenic/anti-apoptotic role in breast cancer cells through caspase-3, Fas-associated death domain (FADD), receptor-interacting protein 1 (RIP-1), apoptotic peptidase activation factor-1 (APAF-1), and Bcl-2 [50]. Here, RIPK1 is linked to breast carcinoma.